Phase II study of pembrolizumab and lenvatinib in advanced well-differentiated neuroendocrine tumors
2024 · ESMO Open · 16 citations
https://doi.org/10.1016/j.esmoop.2024.102386
Tanta University(EG)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
59
Papers
396
Citations
12
h-index
13
i10-index
Mintallah Haider is an academic researcher from Tanta University. The author has contributed to research in topics: Neuroendocrine Tumor Research Advances & Lung Cancer Research Studies & Neuroblastoma Research and Treatments. The author has an h-index of 12, co-authored 51 publications.
https://doi.org/10.1016/j.esmoop.2024.102386
https://doi.org/10.1016/j.pecinn.2023.100248
https://doi.org/10.1016/j.ijrobp.2024.07.1065
Click to start Chat